Other, well-recognized adverse prognostic factors for the achievement of favorable response among patients with del(5)q are age, performance status, transfusion-dependency, thrombocytopenia, increased BM blasts, and complex cytogenetics at baseline [62,63], as well as the presence of TP53 mutations [64]. This evidence concerns the gene TP53 and Thrombocytopenia.